Microplasma is an advanced, non-invasive resurfacing technology, based on radio frequency energy. With a range of applicator tips for even greater versatility, it delivers a safe treatment with enhanced results. The practitioner can control the desired ablation effect – light, moderate or intense – and choose from in-motion or stationary operating techniques, depending on the condition and needs of the patient. Clinically proven to be safe and effective for all skin types, microplasma treatments are extremely fast, and can be carried out by non-medical staff, with minimal training.
Skin resurfacing and tightening is one of the most in-demand indications in today’s aesthetics market. With its proprietary fractional plasma RF technology, microplasma, Alma sets a new standard, enabling greater flexibility and convenience for customized treatment of numerous indications, with impressive results.
What is Microplasma?
How does microplasma work?
High RF energy emitted from the applicator ionizes nitrogen and oxygen atoms in the air, resulting in plasma sparks that cause skin ablation, creating ablative micro-channels.
The micro-injuries caused by the perforation of the skin result in a simultaneous dermal thermal effect that stimulates fibroblasts, contributing to the formation of new collagen. Epidermal tissue regeneration is further assisted by the fact that the surrounding skin is left undamaged.
The Alma Advantages
Beauty Backed by Science
Innovation is a serious business for us at Alma. It’s what enables us to come up with market leading – and market changing – technologies, such as microplasma. Having accumulated deep knowledge and broad clinical expertise over the course of more than two decades in the aesthetics industry, we pride ourselves on developing an unparalleled range of products that are supported by patents, approved treatment protocols and clinical evidence. And while others may say that too, we have the numbers to back it up.
- +organic patents
- Technologies (and growing)
- global awards
- inhouse publications
Frequently asked questions
-
Yes. Accent Prime is indicated for Fitzpatrick skin types I to VI, including the thin, delicate areas of the face. Opus and Alma Hybrid are also indicated for skin types I to VI. Adjustable energy settings and Alma Hybrid’s HyGrid ratio let clinicians choose gentler protocols for thin periorbital skin and darker skin types.
-
In the 2025 Opus microplasma study, patients had one to two sessions, four to sixteen weeks apart. Alma reports that microplasma gives results comparable to ablative lasers with less downtime. Alma Hybrid lets clinicians adjust the ablative to non-ablative laser ratio, so downtime can be matched to each patient’s schedule.
-
Alma has three platforms for the eye area. Accent Prime offers RF and RF pixel applicators for eyelids. Opus delivers fractional RF microplasma for resurfacing and tightening. Alma Hybrid combines ablative CO2 and non-ablative 1570nm laser, and a 2023 Dermatologic Surgery study assessed its safety and efficacy for periorbital rejuvenation.
-
Two published studies support it. Verner (Dermatologic Therapy, 2020) described ablative RF microplasma as a non-surgical blepharoplasty for dermatochalasis. Hsu (Journal of Drugs in Dermatology, 2025) treated 13 patients with Opus microplasma. Blinded evaluators rated significant improvement after one to two sessions, with no serious adverse events.
-
Yes. Microplasma is a fractional RF technology that creates micro-channels in the skin, combining surface ablation with dermal coagulation to tighten loose eyelid skin. It is studied as a non-surgical blepharoplasty for dermatochalasis. Alma offers it on Opus and Accent Prime, which has dedicated RF and RF pixel applicators for the eye area.